the past few years, JGIM has published some of the leading research in this area. For example, a critical role for outpatient general internists is screening for unhealthy drug and alcohol use, but screening is often difficult to implement in a busy clinic. Brief singleitem screening questions (SISQs) for alcohol and other substance use can facilitate screening in health care settings, but are not widely used. In an earlier issue of JGIM, McNeely et al. 4 reported on a single-item screening question for unhealthy alcohol and drug use in primary care patients. The drug SISQ asked, BHow many times in the past year have you used an illegal drug or used a prescription medication for non-medical reasons (for example, because of the experience or feeling it caused)?^While they found that the SSIQ was less accurate than longer interviewer-administered instruments, it was much easier to implement and more likely to retain its fidelity in a busy practice setting.
In this issue of JGIM, two new studies examine different aspects of the knotty problem of chronic pain and opioid misuse. Calcaterra et al. investigate opioid prescribing at hospital discharge among opioid-naïve patients. 5 This retrospective cohort study of more then 6,000 opioid-naïve medical and surgical patients discharged from a safety net hospital found that opioid receipt at hospital discharge among these patients was associated with future chronic opioid use. Unwittingly perhaps, physicians may contribute to the problem of opioid dependence while searching for solutions.
Also in this issue, Alford et al. 6 report on a study of adult patients who screened positive for illicit drug use or prescription drug misuse. Of the 589 participants, 87 % reported chronic pain, with about three-quarters reporting pain-related dysfunction; nearly one-third reported severe pain and severe pain-related dysfunction. Many of these patients reported using alcohol and misusing prescription drugs for self-medication of pain. The authors conclude that primary care doctors must remember to address pain complaints when counseling patients about their substance use.
While prescription opioid sales in the United States have increased by 300 % since 1999, self-reporting of pain among Americans has not changed significantly. 7 The undeniable reality is that we aren't just witnesses to the problem; we are contributors. But we can also be part of the solution-by contributing to research, clinical care, education and policy that seeks to navigate the narrow shoals between two epidemics.
